Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives-Reference-Cited by-同舟云学术

Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives

Published:2019-05-22 Issue:11 Volume:15 Page:2624-2636
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Dos Santos Gaël¹^ORCID

Affiliation:

1. US/BE Vaccine Research and Development Center, Clinical R&D, GSK, Wavre, Belgium

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/21645515.2019.1608745

Reference55 articles.

1. World Health Organization. Influenza. WHO recommendations on the composition of influenza virus vaccines. 2018. [accessed 2018 Dec]. http://www.who.int/influenza/vaccines/virus/recommendations/en/

2. A report on the status of vaccination in Europe

3. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate

4. European Medicines Agency. Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU. (EMA/PRAC/222346/2014). 2014. [accessed 2018 Dec]. https://www.ema.europa.eu/documents/scientific-guideline/interim-guidance-enhanced-safety-surveillance-seasonal-influenza-vaccines-eu_en.pdf

5. European Medicines Agency. Guideline on influenza vaccines. Non-clinical and clinical model. (EMA/CHMP/VWP/457259/2014). 2016. [accessed 2018 Dec]. https://www.ema.europa.eu/documents/scientific-guideline/influenza-vaccines-non-clinical-clinical-module_en.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Just-world beliefs are associated with influenza vaccine intake intent in the United Arab Emirates: a cross-sectional study;Humanities and Social Sciences Communications;2024-04-11

2. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older;Drug Safety;2024-03-14

3. Fear of Needles and Seasonal Influenza Vaccine Acceptance Amongst Adults in the United Arab Emirates: A Cross-Sectional Study and Implications for Nursing;SAGE Open Nursing;2024-01

4. The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands;Drug Safety;2023-10-26

5. Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote monitoring;Influenza and Other Respiratory Viruses;2023-03